Arch Therapeutics, Inc. (ARTHQ)

ATSG Revenue

Arch Therapeutics had revenue of $30.91K in the quarter ending June 30, 2024, with 132.55% growth. This brings the company's revenue in the last twelve months to $148.16K, up 292.25% year-over-year. In the fiscal year ending September 30, 2023, Arch Therapeutics had annual revenue of $75.72K with 383.80% growth.

• Revenue (ttm): 148.16K
• Revenue Growth: +292.25%
• P/S Ratio: 0.00
• Revenue / Employee: 18.52K
• Employees: 8
• Market Cap: 4.00

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2023	75.72K	60.07K	383.80%
Sep 30, 2022	15.65K	4.09K	35.34%
Sep 30, 2021	11.57K	-	-
Sep 30, 2020	-	-	-
Sep 30, 2019	-	-	-